Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 83 of 136 for:    (domestic or partner) AND (violence OR abuse)

Bandebereho Father Groups Randomized Control Trial in Rwanda

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02694627
Recruitment Status : Completed
First Posted : February 29, 2016
Last Update Posted : April 4, 2017
Sponsor:
Collaborator:
Rwanda Men's Resource Center (Rwamrec)
Information provided by (Responsible Party):
Promundo, United States

Brief Summary:
This study seeks to assess the impact of the MenCare+/Bandebereho fathers'/couples' group education intervention on men's attitudes towards, and participation in, sexual and reproductive health, maternal, newborn and child health, and equitable and non-violent relationships with their children and partners.

Condition or disease Intervention/treatment Phase
Gender Relations Prenatal Care Partner Communication Contraception Violence Behavioral: MenCare+/Bandebereho fathers'/couples' group education Not Applicable

Detailed Description:
This study seeks to assess the impact of the MenCare+/Bandebereho fathers'/couples' group education intervention on men's attitudes towards, and participation in, sexual and reproductive health, maternal, newborn and child health, and equitable and non-violent relationships with their children and partners. The MenCare+/ Bandebereho program is a multi-component comprehensive intervention being implemented by the Rwanda Men's Resource Center (RWAMREC) and Promundo-US, in collaboration with the Rwanda Ministry of Health and local authorities in Karongi, Musanze, Nyaruguru and Rwamagana districts. The proposed study will evaluate one component of the program, a 15-session group education intervention targeting young fathers and mothers. The impact of the fathers' group education will be assessed through a randomized control trial design with an intervention arm of men and women participating in the father groups and a control arm of men and women who do not participate in the intervention. The study will collect quantitative and qualitative data over a period of approximately three years.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 2400 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Bandebereho Father Groups: a Randomized Control Trial to Assess the Impact of Maternal, Newborn and Child Health Group Education for New and Expecting Fathers
Actual Study Start Date : February 2015
Actual Primary Completion Date : January 2017
Actual Study Completion Date : January 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention
See intervention description
Behavioral: MenCare+/Bandebereho fathers'/couples' group education
MenCare+/Bandebereho is a 3 year project to engage men in maternal, newborn and child health (MNCH) and in sexual and reproductive health in Rwanda. A core component of the project is fathers'/couples' group education. The target participants are first-time parents or parents of young children living in 16 rural and semi-urban sectors selected by the implementing partner in collaboration with local authorities. The MenCare+/Bandebereho fathers'/couples' group education engages men in 15 weekly sessions of group discussion, critical reflection and interactive activities led by a trained facilitator using a curriculum developed by RWAMREC and Promundo and approved by the Rwandan Ministry of Health, adapted from the Program P Manual. Men's partners participate in 6-8 sessions. The sessions focus on men's role in MNCH, family planning, sharing household responsibilities, intimate partner violence, conflict resolution, family budgeting, and gender equality.
Other Name: Program P

No Intervention: Control
Participants randomized into the control arm are surveyed at the same time points as intervention participants, but do not receive any intervention.



Primary Outcome Measures :
  1. Gender division of caregiving/domestic tasks (from questionnaire: a) composite capturing frequency of the respondent doing household or caregiving tasks; b) composite capturing how tasks are shared between partners). [ Time Frame: 4 months post intervention ]
  2. Men's participation in family planning and maternal, newborn and child health (from questionnaire: a) men's presence at antenatal care visits; b) women's reports of receiving partner support during pregnancy; c) use of family planning). [ Time Frame: 4 months post intervention ]
  3. Gender-related attitudes (from questionnaire: a continuous scale variable, adapted from the validated Gender Equitable Men (GEM) scale). [ Time Frame: 4 months post intervention ]
  4. Women's experiences of intimate partner violence (from: questionnaire: a composite capturing exposure to a standard set of violent acts by a partner). [ Time Frame: 4 months post intervention ]

Secondary Outcome Measures :
  1. Use of violence/harsh punishment against children (from questionnaire: a composite capturing respondents' use of various harsh discipline acts in the past month, adapted from the UNICEF MICS study). [ Time Frame: 4 months post intervention ]
  2. Relationship quality measured (from questionnaire: a) frequency of quarreling and b) quality scale adapted from the Decision Making in Low-Income Couples). [ Time Frame: 4 months post intervention ]
  3. Couple communication (from questionnaire: a composite capturing frequency of communication across multiple topics). [ Time Frame: 4 months post intervention ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Men aged 21-35 years
  • Living with a partner
  • Expectant (or soon to be) father or father of young children under-5
  • Living in an area with a group facilitator

Exclusion Criteria:

- Participated in previous cycles of the same intervention


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02694627


Sponsors and Collaborators
Promundo, United States
Rwanda Men's Resource Center (Rwamrec)
Investigators
Layout table for investigator information
Principal Investigator: Kate E Doyle, MA Promundo-US
Principal Investigator: Ruti G Levtov, PhD Promundo-US
Principal Investigator: Gary Barker, PhD Promundo-US
Principal Investigator: Shamsi Kazimbaya, MA formerly at Rwanda Men's Resource Center, now at Jhpiego

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Promundo, United States
ClinicalTrials.gov Identifier: NCT02694627     History of Changes
Other Study ID Numbers: 137D
First Posted: February 29, 2016    Key Record Dates
Last Update Posted: April 4, 2017
Last Verified: April 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Promundo, United States:
gender, caregiving, MNCH, violence, sexual and reproductive health, parenting